|
Online Database of Chemicals from Around the World | Search | Submit | Advertise | |
Home >> Chemical Listing >> INCB18424>> Market Analysis Reports |
Market Analysis Reports of INCB18424 |
|
Incyte Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... for hematologic and oncology indications, INCB18424, is in Phase III development for myelofibrosis ... Therapeutic Class Overview: Psoriasis – Plaque Psoriasis & Psoriatic Arthritis: Novel Oral Drugs and Biologics to Change Future Treatment Paradigm Over the last decades, therapeutic options for Plaque Psoriasis (PsO) and Psoriatic Arthritis (PsA) have expanded considerably and improved patients’ pain, function, and quality of life. Approved biologics fill in a critical unmet need of limited efficacy ... |